Nektar Therapeutics (NKTR) Other Non-Current Assets (2010 - 2026)

Nektar Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 108.44% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $11.2 million (up 108.44% YoY), while the FY2025 annual figure was $14.1 million, up 204.28% from the prior year.
• Other Non-Current Assets was $11.2 million for Q1 2026 at Nektar Therapeutics, down from $14.1 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $14.1 million in Q4 2025 to a low of $1.4 million in Q1 2023.
• Historically, Other Non-Current Assets has averaged $4.7 million across 5 years, with a median of $4.5 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Other Non-Current Assets jumped 549.42% in 2022, then dropped 26.05% in 2023.
• A 5-year view of Other Non-Current Assets shows it stood at $2.2 million in 2022, then surged by 106.86% to $4.6 million in 2023, then gained by 0.06% to $4.6 million in 2024, then soared by 204.28% to $14.1 million in 2025, then decreased by 20.53% to $11.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $11.2 million (Q1 2026), $14.1 million (Q4 2025), and $5.2 million (Q3 2025), per Business Quant data.